The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
This session addresses the latest information on the pharmacological treatment of movement disorders in the older adult population, with a specific focus on Parkinson’s disease.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 4/29/2025.
Requirements for Successful Completion: Complete the learning activity in its entirety and complete the online nursing continuing professional development evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.
Disclosure of relevant financial relationships with ineligible companies (planners, faculty/speakers, reviewers):
Planning Committee Disclosures: There are no Planning Committee disclosures to declare.
Speakers Disclosures: There are no speaker disclosures to declare.
Commercial Support: No commercial support declared.
Accreditation Statement: This educational activity is jointly provided by Anthony J. Jannetti, Inc. (AJJ) and the Gerontological Advanced Practice Nurses Association (GAPNA).
Anthony J Jannetti, Inc. is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
Anthony J. Jannetti, Inc. is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 5387.
Learning Outcome: After completing this learning activity, the participant will be able to describe the latest information on pharmacological treatment of movement disorders in the elderly adult population, with a specific focus on Parkinson's disease.
Purchasing this session will automatically provide ownership of all the individually purchasable attached CE products, regardless of their stated individual purchase restrictions.
This session provides an overview of the most commonly used antihyperglycemic medications on the market, including a review of the most current ADA/AACE A1c goals, along with geriatric considerations…
This session relates the pathophysiology of osteoporosis to pharmaco-therapeutic algorithms used in the management of the disease. Risks and benefits of osteoporosis pharmacotherapy are addressed…
This session provides an overview of common respiratory medications used in the management of COPD, asthma, and other respiratory disorders in older adults…
Privacy Policy Update: We value your privacy and want you to understand how your information is being used. To make sure you have current and accurate information about this sites privacy practices please visit the privacy center by clicking here.